FDA Advisory Panel Rejects Controversial Alzheimer's Drug
A Food and Drug Administration advisory committee voted that studies of the drug aducanumab for Alzheimer's treatment don't show it's effective.
[Copyright 2020 NPR]
You make this possible. Support our independent, nonprofit newsroom today.
Give Now[Copyright 2020 NPR]